Fundraising Fox尚健生物 (Sumgen Bio)
Hangzhou, CN · 1 known investors
Find your way into 尚健生物 (Sumgen Bio)
Sign up to see every warm intro you have to 尚健生物 (Sumgen Bio)
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 尚健生物 (Sumgen Bio) team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Hangzhou Sumgen Biotech is a biopharmaceutical company that develops innovative antibody drugs, including monoclonal antibodies and antibody-drug conjugates (ADCs), for the treatment of cancer and other diseases. Its lead product, enlonstobart (Enshuxing®), received marketing approval from China's NMPA.
Investors · 1
Frequently asked questions
- What does 尚健生物 (Sumgen Bio) do?
- Hangzhou Sumgen Biotech is a biopharmaceutical company that develops innovative antibody drugs, including monoclonal antibodies and antibody-drug conjugates (ADCs), for the treatment of cancer and other diseases. Its lead product, enlonstobart (Enshuxing®), received marketing approval from China's NMPA.
- Who are 尚健生物 (Sumgen Bio)'s investors?
- 尚健生物 (Sumgen Bio)'s investors include Addor Capital.
- Where is 尚健生物 (Sumgen Bio) headquartered?
- 尚健生物 (Sumgen Bio) is headquartered in Hangzhou, CN.